Fig. 1From: The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technologyVenn diagram of Russian patients with hypertrophic cardiomyopathy and GLA gene variants (pathogenic, likely pathogenic, or VUS), low α-gal A activity and elevated lyso-Gb3 levels in DBSBack to article page